Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Vellenga

Showing results (11-20 of 244) with videos related to

Pageof 25
Sort By:
La Ricerca in Clinica E in Laboratorio|July 1, 1984
Congenital deficiencies in alpha 2-antiplasminC Kluft, H K Nieuwenhuis, E Vellenga
Thrombosis and Haemostasis|June 24, 1985
Thrombotic complications during L-asparaginase related to protein C deficiency?E Vellenga, A W Broekmans, C Kluft
The Netherlands Journal of Medicine|January 1, 1983
Paroxysmal nocturnal haemoglobinuriaE Vellenga, N H Mulder, T H The
Leukemia|August 1, 1996
Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-kappa B) which are involved in IL-6 regulationW H Dokter, S B Koopmans, E Vellenga
Annals of Hematology|December 6, 2001
Abnormal platelet adhesion on abdominal vessels in asymptomatic patients with paroxysmal nocturnal hemoglobinuriaH Louwes, E Vellenga, J T de Wolf
Leukemia|December 1, 1994
The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 casesA Sprikkelman, J T de Wolf, E Vellenga
Clinical and Laboratory Haematology|January 1, 1981
Immunological dysfunction in paroxysmal nocturnal haemoglobinuriaE Vellenga, N H Mulder, T H The
Leukemia|October 30, 2001
Effects of overexpression of the SH2-containing inositol phosphatase SHIP on proliferation and apoptosis of erythroid AS-E2 cellsA K Boer, A L Drayer, E Vellenga
Critical Reviews in Oncology/Hematology|March 3, 1998
Gene expression, biological effects and clinical aspects of lymphokinesL M Tuyt, W H Dokter, E Vellenga
Lancet (London, England)|March 22, 1980
Antithrombin III deficiency during asparaginase therapyE Vellenga, N H Mulder, H O Nieweg
Pageof 25

Showing results (11-20 of 244) with videos related to

Sort By:
Pageof 25
La Ricerca in Clinica E in Laboratorio|July 1, 1984
Congenital deficiencies in alpha 2-antiplasminC Kluft, H K Nieuwenhuis, E Vellenga
Thrombosis and Haemostasis|June 24, 1985
Thrombotic complications during L-asparaginase related to protein C deficiency?E Vellenga, A W Broekmans, C Kluft
The Netherlands Journal of Medicine|January 1, 1983
Paroxysmal nocturnal haemoglobinuriaE Vellenga, N H Mulder, T H The
Leukemia|August 1, 1996
Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6 and NF-kappa B) which are involved in IL-6 regulationW H Dokter, S B Koopmans, E Vellenga
Annals of Hematology|December 6, 2001
Abnormal platelet adhesion on abdominal vessels in asymptomatic patients with paroxysmal nocturnal hemoglobinuriaH Louwes, E Vellenga, J T de Wolf
Leukemia|December 1, 1994
The application of hematopoietic growth factors in drug-induced agranulocytosis: a review of 70 casesA Sprikkelman, J T de Wolf, E Vellenga
Clinical and Laboratory Haematology|January 1, 1981
Immunological dysfunction in paroxysmal nocturnal haemoglobinuriaE Vellenga, N H Mulder, T H The
Leukemia|October 30, 2001
Effects of overexpression of the SH2-containing inositol phosphatase SHIP on proliferation and apoptosis of erythroid AS-E2 cellsA K Boer, A L Drayer, E Vellenga
Critical Reviews in Oncology/Hematology|March 3, 1998
Gene expression, biological effects and clinical aspects of lymphokinesL M Tuyt, W H Dokter, E Vellenga
Lancet (London, England)|March 22, 1980
Antithrombin III deficiency during asparaginase therapyE Vellenga, N H Mulder, H O Nieweg
Pageof 25